TrialJournal of clinical hypertension (Greenwich, Conn.)2017

Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African-American patients with hypertension.

Wallace Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.